» Articles » PMID: 8130269

Effect of Pulmonary Surfactant Protein A (SP-A) and Calcium on the Adsorption of Cholesterol and Film Stability

Overview
Specialties Biochemistry
Biophysics
Date 1994 Mar 24
PMID 8130269
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

The effect of exogenous cholesterol on the stability of surface films at 37 degrees C from various surfactants was studied with the pulsating bubble surfactometer. Addition of cholesterol (5%, w/w) to bovine lipid extract surfactant (bLES) or mixtures of dipalmitoylphosphatidylcholine/1-palmitoyl-2-oleoyl-phosphatidylglycerol /SP-B (7:3:1%) dispersed in 1.5 mM CaCl2/0.9% NaCl resulted in unstable surface films. Although 10% cholesterol only partially impaired the surface activity of bLES, it virtually abolished that of the reconstituted surfactant. The inhibitory effects of cholesterol were significantly repressed by SP-A (10%, w/w of lipid) and 3 mM CaCl2 or 5 mM CaCl2 without SP-A. Adsorption of cholesterol from various surfactants into the air/water interface was examined by measuring the surface radioactivity of [14C]cholesterol. Cholesterol alone dispersed in 1.5 mM CaCl2/0.9% NaCl could not adsorb to the interface, but it adsorbed readily when mixed with bLES. Cholesterol adsorption was markedly suppressed by SP-A in 3 mM CaCl2/0.9% NaCl or 5 mM CaCl2/0.9% NaCl without SP-A. Electron microscopy revealed striking ultrastructural differences between bLES/5% cholesterol/10% SP-A in 3 mM CaCl2/0.9% NaCl and bLES/5% cholesterol in 3 or 5 mM CaCl2/0.9% NaCl. The former exhibited large multilayer and small unilamellar vesicles, while the latter displayed condensed patches of aggregates. Adsorption studies showed aggregated patches adsorbed more rapidly than vesicles but attained lower equilibrium surface pressures. These results indicate SP-A and calcium limit the adsorption of surfactant cholesterol to the air-water interface.

Citing Articles

Atomic force microscopy studies of functional and dysfunctional pulmonary surfactant films. I. Micro- and nanostructures of functional pulmonary surfactant films and the effect of SP-A.

Zuo Y, Keating E, Zhao L, Tadayyon S, Veldhuizen R, Petersen N Biophys J. 2008; 94(9):3549-64.

PMID: 18212010 PMC: 2292375. DOI: 10.1529/biophysj.107.122648.


Metal nanoparticle pollutants interfere with pulmonary surfactant function in vitro.

Bakshi M, Zhao L, Smith R, Possmayer F, Petersen N Biophys J. 2007; 94(3):855-68.

PMID: 17890383 PMC: 2186259. DOI: 10.1529/biophysj.107.106971.


Effect of cholesterol on the biophysical and physiological properties of a clinical pulmonary surfactant.

Keating E, Rahman L, Francis J, Petersen A, Possmayer F, Veldhuizen R Biophys J. 2007; 93(4):1391-401.

PMID: 17526587 PMC: 1929052. DOI: 10.1529/biophysj.106.099762.


Patients with ARDS show improvement but not normalisation of alveolar surface activity with surfactant treatment: putative role of neutral lipids.

Markart P, Ruppert C, Wygrecka M, Colaris T, Dahal B, Walmrath D Thorax. 2007; 62(7):588-94.

PMID: 17287298 PMC: 2117258. DOI: 10.1136/thx.2006.062398.


Alveolar epithelial type II cell: defender of the alveolus revisited.

Fehrenbach H Respir Res. 2001; 2(1):33-46.

PMID: 11686863 PMC: 59567. DOI: 10.1186/rr36.